7.50Open7.50Pre Close0 Volume1 Open Interest68.00Strike Price0.00Turnover65.48%IV3.67%PremiumNov 29, 2024Expiry Date4.83Intrinsic Value100Multiplier4DDays to Expiry2.67Extrinsic Value100Contract SizeAmericanOptions Type0.8439Delta0.0464Gamma13.74Leverage Ratio-0.1511Theta0.0066Rho11.60Eff Leverage0.0189Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet